Tohoku University Technology: Method for Suppressing Tumorigenesis of iPS Cells: T18-512
The potential for bone regeneration technology through the transplantation of cultured bone derived from iPS cells has expanded due to statin treatment!
Tumor formation at the transplantation site of iPS cells is one of the biggest challenges for the application of iPS cells in regenerative medicine. The present invention is a technique that suppresses tumor formation, which is a problem when transplanting iPS cells for bone regeneration, by using statin-based drugs. It is expected to significantly advance the realization of bone regenerative medicine using iPS cells, as it contributes to solving the issue of tumor formation without the need for complicated procedures such as cell sorting.
- Company：Tohoku Techno Arch Co., Ltd.
- Price：Other
